New treatment option for Peri-implant Health
Official title Effect of Probe Material on Peri-implant Probing
ClinicalTrials.gov ID: NCT07304752
What this study is testing
- What it's testing
- Evaluate whether the type of probe (plastic vs. metallic) modifies the accuracy of peri-implant probing in single-unit implants, by comparing the probing depth recorded with the prosthesis in place versus without the prosthesis (ΔPD, mm).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults (≥18 years)
- Presence of at least one single-unit bone-level implant rehabilitated with a screw-retained prosthesis directly connected to the implant (no...
- Implant in function for at least 1 year after prosthetic loading
- No pathological bone loss on periapical radiograph (distance from the most coronal rough surface of the implant to the bone crest \< 3 mm)
- Ability to understand and sign informed consent
You likely can't join if
- Cement-retained restorations or prostheses that cannot be removed
- Systemic antibiotic or anti-inflammatory treatment within the previous 3 months
- Pregnancy or lactation
- Peri-implant treatment within the previous 3 months
- Participation in another clinical trial within the last 30 days
See the full eligibility criteria
- Adults (≥18 years)
- Presence of at least one single-unit bone-level implant rehabilitated with a screw-retained prosthesis directly connected to the implant (no intermediate abutment)
- Implant in function for at least 1 year after prosthetic loading
- No pathological bone loss on periapical radiograph (distance from the most coronal rough surface of the implant to the bone crest \< 3 mm)
- Ability to understand and sign informed consent
- Peri-implant health or mucositis, defined according to the 2017 World Workshop criteria:
- Health: no clinical signs of inflammation, lack of profuse (line or drop) bleeding on probing, no increase in probing depth compared to previous records, and no progressive bone loss beyond initial remodeling (\<2 mm)...
- Mucositis: presence of bleeding and/or suppuration on probing, no increase in probing depth compared to previous records, and no bone loss beyond initial remodeling (\<2 mm). In the absence of previous radiographs...
- Cement-retained restorations or prostheses that cannot be removed
- Systemic antibiotic or anti-inflammatory treatment within the previous 3 months
- Pregnancy or lactation
- Peri-implant treatment within the previous 3 months
- Participation in another clinical trial within the last 30 days
The study team makes the final eligibility decision.
Where it's taking place
- L'Hospitalet de Llobregat, Barcelona, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include L'Hospitalet de Llobregat, Barcelona, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.